Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by Frogger2on Jan 17, 2016 12:04pm
258 Views
Post# 24466349

ADCOM line

ADCOM line
I find this line from the ADCOM summary interesting. Vague diuscussion talks about MCNA possible being as effective as BCG but too similar in it's machanism? So working as well as BCG but much safer and available is not good enough?

"But in the absence of a control arm, several panelists noted that it was impossible to know whether those

outcomes in fact signified a clear improvement. There was also the issue that, like BCG, or Bacillus

Calmette-Guerin, the precise mechanism of action of MCNA is not known. It's not even clear, others pointed

out, whether MCNA works differently enough from BCG to warrant approval – or whether it relies on BCG to

prime the immune system or might prove handy in a first-line setting"

<< Previous
Bullboard Posts
Next >>